XML 39 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
DISCONTINUED OPERATIONS - Additional Information (Details) (USD $)
3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 0 Months Ended 9 Months Ended 0 Months Ended 12 Months Ended
Sep. 30, 2014
Mar. 31, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Feb. 01, 2012
Sep. 30, 2014
Home Health Services
Mar. 31, 2014
Home Health Services
Sep. 30, 2013
Home Health Services
Sep. 30, 2014
Home Health Services
Sep. 30, 2013
Home Health Services
Feb. 01, 2012
Pharmacy Services Assets Sale
Feb. 01, 2012
Community pharmacy
pharmacy
Sep. 30, 2014
Exjade Litigation
Dec. 23, 2013
Exjade Litigation
All current acquirees
Other Acquisition and Integration Expenses
Dec. 31, 2013
Exjade Litigation
All current acquirees
Other Acquisition and Integration Expenses
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                                  
Reduction in consideration transferred                 $ 500,000                
Consideration received                 59,500,000                
Additional payment received by company               1,100,000                  
Purchase price received by company               60,600,000                  
Reduction in revenue                 300,000                
Revenues 243,959,000 239,300,000 190,631,000 730,377,000 543,974,000                        
Gain (loss) associated with reclassification                 200,000                
Income (Loss) from Continuing Operations, Net of Taxes   25,300,000                              
Gain on sale before income taxes               (11,000)   0 2,056,000 0          
Proceeds from Asset Purchase Agreement             173,800,000   54,200,000                
Gain on sale, before income taxes 0   6,543,000 0 6,550,000               108,100,000        
Number of locations                           27      
Settlement agreement amount                             1,100,000 15,000,000 15,000,000
One time costs related to pharmacy services asset sale reserve $ 12,846,000     $ 12,846,000   $ 16,287,000